150 related articles for article (PubMed ID: 32332631)
1. Association of hepatocellular carcinoma with thiazolidinediones use: A population-based case-control study.
Lai SW; Lin CL; Liao KF
Medicine (Baltimore); 2020 Apr; 99(17):e19833. PubMed ID: 32332631
[TBL] [Abstract][Full Text] [Related]
2. Use of thiazolidinediones and risk of hip fracture in old people in a case-control study in Taiwan.
Lin HF; Liao KF; Chang CM; Lin CL; Lin CH; Lai SW
Medicine (Baltimore); 2017 Sep; 96(36):e7712. PubMed ID: 28885328
[TBL] [Abstract][Full Text] [Related]
3. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
4. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of oral corticosteroids use on risk of hepatocellular carcinoma in high risk populations.
Lai SW; Lin CL; Liao KF
Eur J Intern Med; 2018 Jun; 52():73-77. PubMed ID: 29555406
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
7. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
Liao KF; Lin CL; Lai SW; Chen WC
Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
[TBL] [Abstract][Full Text] [Related]
8. Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study.
Chang SS; Hu HY
BMC Cancer; 2013 Sep; 13():420. PubMed ID: 24041200
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes: A case-control study in Taiwan.
Lai SW; Lin HF; Lin CL; Liao KF
Medicine (Baltimore); 2016 Aug; 95(31):e4455. PubMed ID: 27495077
[TBL] [Abstract][Full Text] [Related]
10. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
Hwang JC; Weng SF; Weng RH
Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
[TBL] [Abstract][Full Text] [Related]
11. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome.
Kasmari AJ; Welch A; Liu G; Leslie D; McGarrity T; Riley T
Am J Med; 2017 Jun; 130(6):746.e1-746.e7. PubMed ID: 28109969
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study.
van Dalem J; Driessen JHM; Burden AM; Stehouwer CDA; Klungel OH; de Vries F; Brouwers MCGJ
Hepatology; 2021 Nov; 74(5):2467-2477. PubMed ID: 34129693
[TBL] [Abstract][Full Text] [Related]
14. Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study.
Hsiao FY; Hsieh PH; Huang WF; Tsai YW; Gau CS
Drug Saf; 2013 Aug; 36(8):643-9. PubMed ID: 23797604
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone use and the risk of bladder cancer.
Kuo HW; Tiao MM; Ho SC; Yang CY
Kaohsiung J Med Sci; 2014 Feb; 30(2):94-7. PubMed ID: 24444539
[TBL] [Abstract][Full Text] [Related]
17. Chronic Viral Hepatitis Signifies the Association of Premixed Insulin Analogues with Liver Cancer Risks: A Nationwide Population-Based Study.
Chiang CH; Kuo CS; Lin WW; Su JH; Chen JD; Huang KC
Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31200528
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
[TBL] [Abstract][Full Text] [Related]
19. Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System.
Ramos-Nino ME; MacLean CD; Littenberg B
BMC Med; 2007 Jun; 5():17. PubMed ID: 17584937
[TBL] [Abstract][Full Text] [Related]
20. Association between colorectal cancer and thiazolidinediones administration in a case-control study.
Liao KF; Lin CL; Lai SW
Biomedicine (Taipei); 2019 Mar; 9(1):4. PubMed ID: 30794151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]